3Naoki Kitagawa,Keisuke Tsutsumi,Masami Niwa,Sei-ichi Yamaga,Takeo Anda,Humayun Khalid,Akihiko Himeno,Kohtaro Taniyama,Shobu Shibata.A selective endothelin ETA antagonist, BQ-123, inhibits125I-endothelin-1 (125I-ET-1) binding to human meningiomas and antagonizes ET-1-induced proliferation of meningioma cells[J]. Cellular and Molecular Neurobiology . 1994 (2)
4Eileen D. Adamson,Anthony R. Rees.Epidermal growth factor receptors[J]. Molecular and Cellular Biochemistry . 1981 (3)
5Schrell VM.1</sub> receptors&sid=The Journal of Clinical Endocrinology&aufirst=Schrell VM');
 ">Growth human cerebral meningiomas is inhibited by dopaminergic agents:Presence of high affinity dopamine-D<sub>1</sub> receptors. The Journal of Clinical Endocrinology . 1990
6Eric F,Adam S.Autocrine control of human meningioma proliferation secretion of platelet-derived growth factor-like molecules. International Journal of Cancer . 1991
7Carperter G,Cohen S.King L et al.Epidermal growth factor. Annual Review of Biochemistry . 1979
8Reubi JC,Horisberger U,Lang W et al.Coincidence of EGF-receptors and somatostatin receptors in meningiomas but inverse differentiation-dependent relationship in glial tumors. American Journal of Pathology . 1989
9Reubi JC,Maurer R,Klijn JGM et al.High incidence of somatostatin receptors in human meningiomas.Biochemical characterization. The Journal of Clinical Endocrinology . 1986
10Lamberts S,Koetsveld P,Verleun T.Prolactin release-in-hibitory effects of progesterone,megestrol acetate and mifepristone(Ru 486) by cultured rat meningiomas. Clinical Endocrinology . 1992
